| Literature DB >> 34718934 |
Antonio Marzollo1,2, Francesca Conti3, Andrea Finocchi4,5, Silvia Bresolin6, Linda Rossini7, Beatrice Rivalta4,5, Lucia Leonardi8, Caterina Tretti6, Francesca Tosato9, Maria Chiriaco5, Giorgiana Madalina Ursu5, Cristina Tea Natalucci7, Maddalena Martella7, Alessandro Borghesi10,11, Cecilia Mancini12, Andrea Ciolfi12, Gigliola di Matteo4,5, Marco Tartaglia12, Caterina Cancrini4,5, Andrea Dotta13, Alessandra Biffi6.
Abstract
Chronic granulomatous disease (CGD) is a rare inborn error of immunity (IEI), characterized by a deficient phagocyte killing due to the inability of NADPH oxidase to produce reactive oxygen species in the phagosome. Patients with CGD suffer from severe and recurrent infections and chronic inflammatory disorders. Onset of CGD has been rarely reported in neonates and only as single case reports or small case series. We report here the cases of three newborns from two different kindreds, presenting with novel infectious and inflammatory phenotypes associated with CGD. A girl with CYBA deficiency presented with necrotizing pneumonia, requiring a prolonged antibiotic treatment and resulting in fibrotic pulmonary changes. From the second kindred, the first of two brothers developed a fatal Burkholderia multivorans sepsis and died at 24 days of life. His younger brother had a diagnosis of CYBB deficiency and presented with Macrophage Activation Syndrome/Hemophagocytic Lympho-Histiocytosis (MAS/HLH) without any infection, that could be controlled with steroids. We further report the findings of a review of the literature and show that the spectrum of microorganisms causing infections in neonates with CGD is similar to that of older patients, but the clinical manifestations are more diverse, especially those related to the inflammatory syndromes. Our findings extend the spectrum of the clinical presentation of CGD to include unusual neonatal phenotypes. The recognition of the very early, potentially life-threatening manifestations of CGD is crucial for a prompt diagnosis, improvement of survival and reduction of the risk of long-term sequelae.Entities:
Keywords: CGD; CYBA; CYBB; HLH; MAS; Necrotizing pneumonia; Newborn
Mesh:
Year: 2021 PMID: 34718934 DOI: 10.1007/s10875-021-01159-4
Source DB: PubMed Journal: J Clin Immunol ISSN: 0271-9142 Impact factor: 8.317